NCT00893516终止2 期
A Multicentre Open-label Dose Escalation Tiral of Zanolimumab in Combination With CHOP Chemotherapy in Patients With CD4 Positive Non-cutaneous Peripheral T-cell Lymphoma With Nodal Involvement.
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 入组人数
- 5
- 主要终点
- Primary Outcome Unavailable
研究概览
简要总结
Evaluation of CD4 in combination with CHO chemotherapy in subjects with nodal involvement of non cutaneous Tcell lymphoma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •study is closed to enrollment
排除标准
- •study is closed to enrollment
研究组 & 干预措施
1
Experimental
CHOP chemo therapy + CD4 therapy
干预措施: CHOP + CD4 (Biological)
2
Active Comparator
CHOP chemotherapy
干预措施: CHOP (Drug)
结局指标
主要结局
Primary Outcome Unavailable
All efforts to obtain data have been exhausted, therefore we have no data available to report.
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
Safety Study of CD-NP in Heart FailureCongestive Heart FailureNCT00557661Nile Therapeutics20
招募中
1 期
CD4CAR for CD4+ Leukemia and LymphomaT-cell LymphomaT-cell LeukemiaNCT03829540Huda Salman20
终止
3 期
Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary SyndromeMycosis FungoidesSezary SyndromeNCT00127881Emergent Product Development Seattle LLC76
已完成
2 期
Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin.Cutaneous T-Cell LymphomaNCT00071071Genmab25
已完成
2 期
Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.Cutaneous T-Cell LymphomaNCT00071084Genmab22